2020
DOI: 10.1016/j.imu.2020.100311
|View full text |Cite
|
Sign up to set email alerts
|

Design protein-protein interaction network and protein-drug interaction network for common cancer diseases: A bioinformatics approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 23 publications
0
14
0
Order By: Relevance
“…Nevertheless, Zhou and Kosorok (2017) method is also applicable to biological networks, such as gene networks or protein-protein networks, when one wants to identify nodes or pathways affected by drug treatments or when one wants to design drug repurposing strategies, or drug combination prediction, and more in general to identify differences between networks of different patients. In this respect, we refer the reader to some significant recent studies such as ( Feng et al, 2017 ; Cheng et al, 2019 ; Hasan et al, 2020 ; Lu et al, 2020 ; Adhami et al, 2021 ; Ruiz et al, 2021 ; Somolinos et al, 2021 ). In this context, the crucial step is the treatment selection rule, or optimal treatment regime.…”
Section: Machine Learning and Structural Causal Modelsmentioning
confidence: 99%
“…Nevertheless, Zhou and Kosorok (2017) method is also applicable to biological networks, such as gene networks or protein-protein networks, when one wants to identify nodes or pathways affected by drug treatments or when one wants to design drug repurposing strategies, or drug combination prediction, and more in general to identify differences between networks of different patients. In this respect, we refer the reader to some significant recent studies such as ( Feng et al, 2017 ; Cheng et al, 2019 ; Hasan et al, 2020 ; Lu et al, 2020 ; Adhami et al, 2021 ; Ruiz et al, 2021 ; Somolinos et al, 2021 ). In this context, the crucial step is the treatment selection rule, or optimal treatment regime.…”
Section: Machine Learning and Structural Causal Modelsmentioning
confidence: 99%
“…The integration of these networks, both vertically and horizontally, can highlight clusters of proteins with central roles, aiding the understanding of drug action mechanisms ( Martin, Roe and Faulon, 2005 ; Dimitrakopoulos et al, 2021 ; Marín-Llaó et al, 2021 ; Tomkins and Manzoni, 2021 ). PPI networks offer prospects in many fields, such as medicine, health and also in agri-food ( Hao et al, 2019 ; Hasan et al, 2020 ; Thanasomboon et al, 2020 ; Charmpi et al, 2021 ). Vertical and horizontal integration algorithms are mainly based on propagation and alignment algorithms but are often combined with machine learning methods to predict the probability of reliability of an interaction ( Li and Ilie, 2017 ; Lee and Nam, 2018 ; Zhang et al, 2018 ; Das and Chakrabarti, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Investigation of protein-drug interactions (PDI) is critical to understand the theoretical underpinnings of agonist selectivity [ 39 , 40 ]. A medicament should first establish the drug-receptor complexes before it can interact with receptor sites or be metabolized by bioindicators [ 41 ].…”
Section: Methodsmentioning
confidence: 99%
“…A medicament should first establish the drug-receptor complexes before it can interact with receptor sites or be metabolized by bioindicators [ 41 ]. Computational approaches can be used to anticipate proteomics for a specific therapeutic agent or to react with medicines for specific target molecules or proteins [ 39 , 42 ]. NetworkAnalyst was used to predict protein-drug interactions in our study [ 43 ].…”
Section: Methodsmentioning
confidence: 99%